Vimarsana
Biggest News Aggregation in the World

Page 4 - Daniel Tass News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel Tass. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Tass Today - Breaking & Trending Today

DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers - Vimarsana News

DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers

Montrouge, France, June 7, 2022 DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers 67.0% of subjects treated with Viaskin...

DBV Technologies S.A.: DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers - Vimarsana News

DBV Technologies S.A.: DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers

Montrouge, France, June 7, 2022 DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers 67.0% of subjects treated

DBV Technologies to Present at the H.C. Wainwright BioConnect 2022 Conference - Vimarsana News

DBV Technologies to Present at the H.C. Wainwright BioConnect 2022 Conference

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
DBV Technologies to Participate in an Upcoming Investor Conference - Vimarsana News

DBV Technologies to Participate in an Upcoming Investor Conference

DBV Technologies to Participate in an Upcoming Investor Conference | Regulatory News

Source: lse.co.uk
DBV Technologies S.A.: DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference - Vimarsana News

DBV Technologies S.A.: DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference

DBV Technologies S.A.: DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference being held March 9-10, 2021. A webcast of the presentation at the H.C. Wainwright Healthcare Conference will be available on the Investors & Media...